Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies

Neoplasma

Volumn 51, Issue 6, 2004, Pages 422-430

  Babusikova O ^a   Stevulova L ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

B cell malignancies; Flow cytometry; Immunophenotyping; Lysed whole blood technique; Surface and cytoplasmic immunoglobulin light heavy chains

Indexed keywords

CD22 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; CELL SURFACE; CYTOLYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEMBRANE PERMEABILITY; SCORING SYSTEM; SURFACE PROPERTY; TECHNIQUE;

EID: 11144245923     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ALMEIDA J, ORFAO A, OCQUETEAU M, MATEO G, CORRAL M et al. High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma. Brit J Haematol 1999; 107: 121-131.
2. BABUŠÍKOVÁ O, MLČÁKOVÁ A. Hairy cell leukamia: early immunophenotype detection and quantitative analysis by flow cytometry. Neoplasma 2003; 50: 350-356.
3. BANGERTER A, HILDEBRAND A, GRIESSHAMMER M. Immunophenotypic analysis of simultaneous specimens from different sites from the same patient with malignant lymphoma. Cytopathol 2001; 12: 168-176.
4. BASSO G, BULDINI B, DE ZEN L, ORFAO A. New methodologic approaches for immunophenotyping acute leukemia. Haematol 2001; 86: 675-692.
5. BOROWITZ MJ, PULLEN DJ, SHUSTER JJ, VISWANATHA D, MONTGOMERY K et al. Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study. Leukemia 2003; 17: 1566-1572.
6. BROHÉE D, CAUCHIE P, DELVAL L, GOVAERTS D, NÉVE P, PIRO P. Frequent discordance of the light-chain isotypes expressed by serum monoclonal components and leukaemic B-cells. Clin Lab Haem 2002; 24: 151-154.
7. CALDWELL ChW, LACOMBE F. Evaluation of peripheral blood lymphocytosis. 2000 Academic Information Systems, USA, p. 125.
8. CAMPANA D. Determination of minimal residual disease in leukemia patients. Review. Brit J Haematol 2003; 121: 823-838.
9. CHANG CC, SCHUR BC, KAMPALATH B, LINDHOLM P, BECKER CG, VESOLE DH. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry. Mod Pathol 2001; 14: 2015-1021.
10. DENEYS V, MAZZON AM, MARQUES JL, BENOIT H, DE BRUYERE M. Reference values for peripheral blood B-lymphocyte subpopulations: a basis for multiparametric immunophenotyping of abnormal lymphocytes. J Immunol Methods 2001; 253: 23-36.
11. DIGIUSEPPE JA, BOROWITZ MJ. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 1998; 25: 6-10.
12. DIRAIMONDO F, ALBITAR M, HUH Z, O'BRIEN S, MONTILLO M et al. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease. Cancer 2002; 94: 1721-1730.
13. DRENOU B, FARDEL O, FAUCHER R, AMIOT L. Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies. Ann Biol Clin (Paris) 2002; 60: 663-672.
14. GHOBRIAL IM, GERTZ MA, FONSECA R. Waldenstrom macroglobulinemia. Review. Lancet Oncol 2003; 4: 679-685.
15. GINALDI L, DE MARTINIS M, MATUTES E, FARAHAT N, MORILLA R, CATOVSKY D. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol 1998; 52: 364-369.
16. GLASOVÁ M, KONÍKOVÁ E, KUSENDA J, BABUŠÍKOVÁ O. Evaluation of different fixation- permeabilization methods for simultaneous detection of surface, cytoplasmic markers and DNA analysis by flow cytometry in some human hematopoietic cell lines. Neoplasma 1995; 42: 337-346.
17. GONG JZ, LAGOO AS, PETERS D, HORVATINOVICH J, BENZ P, BUCKLEY PJ. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Clin Pathol 2001; 116: 893-897.
18. GUILLAUME N, ALIMARDANI G, CAPIOD JC, CLAISSE JF. Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukemia. Ann Biol Clin (Paris) 2002; 60: 673-681.
19. ISHIKAWA H, RSUYAMA N, MAHMOUD MS, FUJII R, ABROUN S et al. CD19 expression and growth inhibition of tumours in human multiple myeloma. Leuk Lymphoma 2002; 43: 613-616.
20. LIN P, MANSOOR A, BUESO-RAMOS C, HAO S, LAI R, MEDEIROS LJ. Diffuse large B-cell lymphoma occuring in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol 2003; 120: 246-253.
21. MATEO G, CORRAL M, ALMEIDA J, LÓPEZ-BERGES C, NIETO MJ et al. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma. J Hematol 2003; 88: 1013-1021.
22. MATUTES E, POLLIACK A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000; 4: 22-47.
23. MLČÁKOVÁ A, BABUŠÍKOVÁ O. Multiparametric flow cytometry in diagnosis and detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype. Neoplasma 2003; 50: 416-421.
24. MONAGHAN SA, PETERSON LC, JAMES C, MARSZALEK L. KHOONG A et al. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL). Cytometry 2003; 56: 30-42.
25. OCQUETEAU M, SAN MIGUEL JF, GONZALES M, ALMEIDA J, ORFAO A. Do myelomatous plasma cells really express surface immunoglobulins? Haematol 1996; 81: 460-463.
26. PANGALIS GA, ANGELOPOULUS MK, VASSILAKOPOULUS TP, SIAKANTARIS MP, KITTAS C. B-chronic lymphocytic leukemia, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders. Semin Hematol 1999; 36: 104-114.
27. SAN MIGUEL JF, ALMEIDA J, MATEO G, BLADÉ J, LOPÉZ-BERGES C et al. Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome. Blood 2002; 99: 1853-1856.
28. SAN MIGUEL JF, VIDRIALES MB, OCIO E, MATEO G. SANCHES-GUIJO F et al. Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol 2003; 38: 187-195.
29. SÁNCHEZ ML, ALMEIDA J, VIDRIALES B, LOPÉZ-BERGES C. GARCIA-MARCOS MA et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 2002; 16: 1460-1469.
30. SANDILANDS GP, HAUFEE B, LOUDON E, MARSH AG, GONDOWIDJOJO A et al. Detection of cytoplasmic CD antigens within normal human peripheral blood leucocytes 2003; 108: 329-337.
31. SCHNEIDER U, VAN LESSEN A, HUHN D, SERKE S. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. Br J Haematol 1997; 97: 56-64.